|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
173,970,000 |
Market
Cap: |
4.71(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.01 - $43.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
2,500 |
115,745 |
1,772,132 |
2,889,102 |
Total Sell Value |
$75,793 |
$4,772,807 |
$61,791,093 |
$73,490,989 |
Total People Sold |
1 |
3 |
6 |
6 |
Total Sell Transactions |
2 |
8 |
16 |
31 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Valantine Hannah |
Director |
|
2023-11-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
|
- |
|
Scott Randal W |
Director |
|
2023-09-05 |
4 |
AS |
$30.00 |
$75,000 |
I/I |
(2,500) |
13,500 |
|
31% |
|
Kumar Neil |
CEO and President |
|
2023-08-17 |
4 |
AS |
$28.59 |
$1,473,784 |
D/D |
(51,552) |
4,813,197 |
|
48% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-08-17 |
4 |
AS |
$28.59 |
$648,455 |
D/D |
(22,683) |
36,710 |
|
48% |
|
Kumar Neil |
CEO and President |
|
2023-08-16 |
4 |
D |
$29.80 |
$1,510,800 |
D/D |
(50,698) |
4,864,749 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,250 |
4,915,447 |
|
- |
|
Homcy Charles J |
Director |
|
2023-08-16 |
4 |
D |
$29.80 |
$38,770 |
D/D |
(1,301) |
1,224,537 |
|
- |
|
Homcy Charles J |
Director |
|
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,225,838 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-08-16 |
4 |
D |
$29.80 |
$664,868 |
D/D |
(22,311) |
59,393 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,994 |
81,704 |
|
- |
|
Shabet Rose Sharon |
|
|
2023-07-18 |
4 |
S |
$35.00 |
$52,500,000 |
I/I |
(1,500,000) |
25,120,991 |
|
9% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-05-17 |
4 |
AS |
$14.01 |
$342,168 |
D/D |
(24,424) |
36,408 |
|
89% |
|
Kumar Neil |
CEO and President |
|
2023-05-17 |
4 |
AS |
$14.01 |
$722,218 |
D/D |
(51,552) |
4,813,197 |
|
89% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-05-16 |
4 |
D |
$14.09 |
$289,859 |
D/D |
(20,572) |
60,832 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,996 |
81,404 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-05-16 |
4 |
D |
$14.09 |
$714,321 |
D/D |
(50,697) |
4,864,749 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,249 |
4,915,446 |
|
- |
|
Homcy Charles J |
Director |
|
2023-05-16 |
4 |
D |
$14.09 |
$18,317 |
D/D |
(1,300) |
1,220,827 |
|
- |
|
Homcy Charles J |
Director |
|
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,222,127 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-05-03 |
4 |
AS |
$14.18 |
$920,693 |
D/D |
(64,929) |
36,408 |
|
98% |
|
Kumar Neil |
CEO and President |
|
2023-05-03 |
4 |
AS |
$14.18 |
$1,701,744 |
I/I |
(120,000) |
1,012,722 |
|
98% |
|
Kumar Neil |
CEO and President |
|
2023-04-05 |
4 |
AS |
$15.46 |
$1,855,656 |
I/I |
(120,000) |
1,132,722 |
|
96% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-04-05 |
4 |
AS |
$15.45 |
$857,697 |
D/D |
(55,500) |
101,337 |
|
96% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-03-03 |
4 |
AS |
$10.96 |
$687,148 |
D/D |
(62,692) |
156,837 |
|
59% |
|
Kumar Neil |
CEO and President |
|
2023-03-03 |
4 |
AS |
$10.96 |
$1,315,224 |
I/I |
(120,000) |
1,252,722 |
|
59% |
|
288 Records found
|
|
Page 2 of 12 |
|
|